North America Opioid Induced Constipation Drug Market Forecast 2017-2025

Publisher Name :
Date: 01-Aug-2017
No. of pages: 51

Key Findings

The North America opioid induced constipation drug market is expected to be the fastest growing market during the forecast period of 2017-2025 with an expected CAGR growth of 5.72%. The revenue generated by the market is expected to increase from $840.4 million in 2016 and reach $1382.73 million by 2025.

Market Insights

The North American OIC drug market is segmented on the basis of the type of prescription and the type of drug. The prescription type market is further divided into prescribed drugs such as branded and generic drugs and the over the counter drugs which do not require any doctor prescription. The market on the type of drug can be further segmented into methyl naltrexone bromide, lubiprostone, naloxegol and pipeline drugs. The increase in healthcare spending, technological advancement in cardiology and growing life style oriented diseases are aiding in the expansion of the market in this region.

Competitive Insights

Some of the major players in the market include

• Ironwood Pharmaceuticals Inc

• Pfizer

• Progenics Pharmaceuticals Inc

• Allergan PLC

• others

North America Opioid Induced Constipation Drug Market Forecast 2017-2025

Table of Contents

1. Research Scope
1.1. Study Goals
1.2. Scope of the Market Study
1.3. Who Will Find This Report Useful?
1.4. Study and Forecasting Years
2. Research Methodology
2.1. Sources of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top Down Approach
2.3. Bottom Up Approach
2.4. Data Triangulation
3. Executive Summary
3.1. Market Summary
4. Market Overview
4.1. Market Definition
4.2. Key Market Insights
4.3. Attractive Investment Scenario
4.4. Positioning of Key Cic Drugs Manufacturers In the Market
4.5. Market Drivers
4.5.1. Rising Use of Opioid
4.5.2. Increasing Geriatric Population
4.5.3. Increasing Opioids Prescription In North America
4.5.4. Easy Availability of Improved and Effective Oic Drugs
4.6. Restraints
4.6.1. Research On Pain and Next Generation Analgesics
4.6.2. Side Effects of Oic Drugs
4.6.3. Unawareness and Ignorance Among Patients
4.7. Opportunity
4.7.1. Increasing Use of Opioids
4.8. Challenges
4.8.1. Large Number of Considerations While Using Opioids
5. North America Oic Drug Market By Drug Type 2017-2025 ($ Million)
5.1. Overview
5.1.1. Methyl Naltrexone Bromide
5.1.2. Lubiprostone
5.1.3. Naloxegol
5.2. Pipeline Drug Analysis: Phase 3: Naldemedine (Year of Launch To 2022 $ Million)
5.3. Pipeline Drug Analysis: Phase 2: Alvimopan, Dolcanatide (Qualitative Information)
5.4. Pipeline Drug Analysis: Phase 3: Elobixibat (Year of Launch To 2022 $ Million)
6. North America Cic Drugs Market By Prescription Type 2017-2025 ($ Million)
6.1. Prescribed Drugs
6.1.1. Branded
6.1.2. Generic
6.2. Over the Counter Drugs
7. Key Analytics
7.1. Porters Five Force Model
7.1.1. Intensity of Competitive Rivalryompetition Among The
7.1.2. Bargaining Power of Suppliers
7.1.3. Bargaining Power of Buyers
7.1.4. Threat of Substitute Products
7.1.5. Threat of New Entrants
7.2. Vendor Landscape
7.3. Opportunity Matrix
8. North America Oic Drugs Market By Countries 2017-2025 ($ Million)
8.1. Us
8.2. Canada
9. Company Profile
9.1. Ironwood Pharmaceuticals Inc
9.1.1. Overview
9.1.2. Product Portfolio
9.1.3. Strategic Moves
9.1.4. Scot Analysis
9.2. Daiichi Sankyo Co Ltd
9.2.1. Overview
9.2.2. Product Portfolio
9.2.3. Strategic Moves
9.2.4. Scot Analysis
9.3. Pfizer
9.3.1. Overview
9.3.2. Product Portfolio
9.3.3. Strategic Moves
9.3.4. Scot Analysis
9.4. Progenics Pharmaceuticals Inc
9.4.1. Overview
9.4.2. Strategic Moves
9.4.3. Scot Analysis
9.5. Shionogi & Co., Ltd.
9.5.1. Overview
9.5.2. Product Portfolio
9.5.3. Strategic Moves
9.5.4. Scot Analysis
9.6. Allergan Plc
9.6.1. Overview
9.6.2. Product Portfolio
9.6.3. Strategic Moves
9.6.4. Scot Analysis
9.7. Nektar Therapeutics
9.7.1. Overview
9.7.2. Product Portfolio
9.7.3. Strategic Moves
9.7.4. Scot Analysis
9.8. Purdue Pharma L.P.
9.8.1. Overview
9.8.2. Product Portfolio
9.8.3. Strategic Moves
9.8.4. Scot Analysis
9.9. S.L.A. Pharma Ag
9.9.1. Overview
9.9.2. Product Portfolio
9.9.3. Scot Analysis
9.10. Mundipharma International Limited
9.10.1. Overview
9.10.2. Product Portfolio
9.10.3. Strategic Moves
9.10.4. Scot Analysis
9.11. Ono Pharmaceutical Co., Ltd.
9.11.1. Overview
9.11.2. Product Portfolio
9.11.3. Strategic Moves
9.11.4. Scot Analysis
9.12. Takeda Pharmaceutical Company Limited
9.12.1. Overview
9.12.2. Product Portfolio
9.12.3. Strategic Moves
9.12.4. Scot Analysis
9.13. Theravance Biopharma Inc
9.13.1. Overview
9.13.2. Product Portfolio
9.13.3. Strategic Moves
9.13.4. Scot Analysis
9.14. Valeant Pharmaceuticals International
9.14.1. Overview
9.14.2. Product Portfolio
9.14.3. Strategic Moves
9.14.4. Scot Analysis
9.15. Cosmo Pharmaceuticals Sa
9.15.1. Overview
9.15.2. Product Portfolio
9.15.3. Strategic Moves
9.15.4. Scot Analysis
9.16. Daewoong Pharmaceutical Co., Ltd.
9.16.1. Overview
9.16.2. Product Portfolio
9.16.3. Strategic Moves
9.16.4. Scot Analysis
9.17. C.B. Fleet Company, Inc.
9.17.1. Overview
9.17.2. Product Portfolio
9.17.3. Strategic Moves
9.17.4. Scot Analysis

List of Tables

Table 1 North America Oic Drug Market By Countries 2017-2025 ($ Million)
Table 2 Pharmacological Approaches To Treat Opioid Induced Constipation
Table 3 Laxatives Used For Opioid Induced Constipation
Table 4 Side Effects of Using Laxatives
Table 5 Patients Unfit For Intake of Opioids
Table 6 North America Oic Drug Market By Drug Type, 2017-2025 ($ Million)
Table 7 Product Profile (Methyl Naltrexone Bromide)
Table 8 Product Profile (Lubiprostone)
Table 9 Product Profile (Naloxegol)
Table 10 Pipeline Product Profile (Naldemedine)
Table 11 Pipeline Product Profile (Alvimopan, Dolcanatide)
Table 12 Pipeline Product Profile (Elobixibat)
Table 13 North America Oic Drug Market By Prescription Type 2017-2025 ($ Million)
Table 14 Product Profile (Lubiprostone)
Table 15 North America Prescribed Oic Drugs Market 2017-2025($ Million)
Table 16 Product Profile (Methyl Naltrexone Bromide)
Table 17 Product Profile (Metamucil)
Table 18 Product Profile (Bisacodyl)
Table 19 North America Oic Drugs Market By Country, 2017-2025($ Million)

List of Figures

Figure 1 North America Oic Drugs Market 2017-2025 ($ Million)
Figure 2 North America Oic Drug Market By Drug Type 2016 and 2025 (%)
Figure 3 North America Oic Drug Market By Prescription Type 2016 (%)
Figure 4 Increasing Number of Opioid Prescription ($ Million)
Figure 5 Reasons For the Growth of Opioid Market.
Figure 6 Therapeutic Opioid Use In Us (G/100,000 Population)
Figure 7 Common Side Effects of Movantik
Figure 8 Major Usage of Opioids
Figure 9 Considerations Taken While the Opioid Usage
Figure 10 North America Methyl Naltrexone Bromide Oic Drug Market 2017-2025 ($ Million)
Figure 11 North America Lubiprostone Oic Drug Market 2017-2025 ($Million)
Figure 12 North America Naloxegol Oic Drug Market 2017-2025 ($ Million)
Figure 13 North America Prescribed Oic Drug Market 2017-2025 ($ Million)
Figure 14 North America Prescribed Branded Oic Drug Market 2017-2025 ($ Million)
Figure 15 North America Prescribed Generic Oic Drug Market 2017-2025 ($ Million)
Figure 16 North America Over the Counter Oic Drug Market 2017-2025 ($ Million)
Figure 17 North America Oic Drugs Market 2017-2025 ($ Million)
Figure 18 Us Oic Drug Market 2017-2025 ($ Million)
Figure 19 Canada Oic Drug Market 2017-2025 ($ Million)
Figure 20 Number of Prescriptions Dispensed For Opioids
  • Diarrhea - Pipeline Review, H1 2018
    Published: 18-Jan-2018        Price: US 2000 Onwards        Pages: 154
    Diarrhea - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diarrhea - Pipeline Review, H1 2018, provides an overview of the Diarrhea (Gastrointestinal) pipeline landscape. Diarrhea is a contagious gastrointestinal infection occurring mostly due to unhygienic conditions. Diarrhea may be related to a viral or bacterial infection and is sometimes the result of food poisoning. Symptoms inc......
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) - Pipeline Review, H1 2018
    Published: 18-Jan-2018        Price: US 2000 Onwards        Pages: 79
    Reflux Esophagitis (Gastroesophageal Reflux Disease) - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Reflux Esophagitis (Gastroesophageal Reflux Disease) - Pipeline Review, H1 2018, provides an overview of the Reflux Esophagitis (Gastroesophageal Reflux Disease) (Gastrointestinal) pipeline landscape. When the liquid content of the stomach refluxes into the oesophagus, that condition ......
  • Colitis - Pipeline Review, H1 2018
    Published: 18-Jan-2018        Price: US 2000 Onwards        Pages: 93
    Colitis - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colitis - Pipeline Review, H1 2018, provides an overview of the Colitis (Gastrointestinal) pipeline landscape. Colitis is swelling (inflammation) of the large intestine (colon). Colitis can have many different causes, including infections, including those caused by a virus, parasite, and food poisoning due to bacteria, inflammat......
  • Functional (Non Ulcer) Dyspepsia - Pipeline Review, H1 2018
    Published: 18-Jan-2018        Price: US 2000 Onwards        Pages: 34
    Functional (Non Ulcer) Dyspepsia - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Functional (Non Ulcer) Dyspepsia - Pipeline Review, H1 2018, provides an overview of the Functional (Non Ulcer) Dyspepsia (Gastrointestinal) pipeline landscape. Non-ulcer dyspepsia is a term used to describe signs and symptoms of indigestion that have no obvious cause. Non-ulcer dyspepsia is also called ......
  • United States Lansoprazole Market Report 2018
    Published: 17-Jan-2018        Price: US 3800 Onwards        Pages: 110
    In this report, the United States Lansoprazole market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rate of Lan......
  • Global Esomeprazole Market Research Report 2018
    Published: 17-Jan-2018        Price: US 2900 Onwards        Pages: 116
    In this report, the global Esomeprazole market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Esomeprazole in these regions, from 2013 to 2025 (forecast), covering - North America - Europe - China - Japan......
  • Global Irritable Bowel Syndrome (IBS) Market Research Report 2018
    Published: 12-Jan-2018        Price: US 3500 Onwards        Pages: 131
    Summary Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimate......
  • Global Gastrointestinal Drugs Market Size, Status and Forecast 2025
    Published: 10-Jan-2018        Price: US 3300 Onwards        Pages: 92
    This report studies the global Gastrointestinal Drugs market, analyzes and researches the Gastrointestinal Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Abbott Laboratories - Allergan - AstraZeneca - Bayer - Boehringer Ingelheim - GlaxoSmithKline - Janssen Biotech - Sanofi - Takeda Pharmaceutical - Valeant Phar......
  • Global Anti Peptic Ulcer Drugs Market Size, Status and Forecast 2025
    Published: 10-Jan-2018        Price: US 3300 Onwards        Pages: 104
    This report studies the global Anti Peptic Ulcer Drugs market, analyzes and researches the Anti Peptic Ulcer Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Eisai - Daewoong Pharmaceutical - Takeda Pharmaceutical - HeliCure - AstraZeneca - Ore Pharmaceuticals - Sihuan Pharmaceutical - GlaxoSmithKline - Pfizer - A......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs